CBP 400
Generic Name: cefditoren
Pill imprint CBP 400 has been identified as Spectracef 400 mg.
Spectracef is used in the treatment of skin infection; bronchitis; pneumonia; tonsillitis/pharyngitis; skin and structure infection and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy.
Spectracef 400 mg is not subject to the Controlled Substances Act.
See also related documents.
Spectracef Images
- Generic Name:
- cefditoren
- Imprint:
-
CBP 400
- Strength:
- 400 mg
- Color:
- White
- Size:
- 5.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
mannitol
magnesium stearate
sodium caseinate
sodium tripolyphosphate
hydroxypropyl cellulose
carnauba wax
polyethylene glycol
titanium dioxide
- Drug Class:
- Third generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Cornerstone BioPharma Inc
- National Drug Code (NDC):
- 10122-0802
Advertisement
More Spectracef resources
- Spectracef (Wolters Kluwer)
- Spectracef (Cerner Multum)
- Spectracef (Micromedex) - Includes Dosage Information
- Spectracef (AHFS DI)
- Spectracef (FDA)
Search Again
